About Aflatoxin B1 aldehyde reductase member 2
Aflatoxin B1 aldehyde reductase member 2 (AKR7A2) is a protein
from Homo sapiens identified by UniProt accession
O43488, 359 residues long.
MolForge cross-references it against 0 known binders and
48 disease associations.
Target properties
| Protein name | Aflatoxin B1 aldehyde reductase member 2 |
| UniProt accession | O43488 |
| Gene | AKR7A2 |
| Organism | Homo sapiens |
| Length | 359 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (48)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.52
- lysosomal storage disease · score 0.37
- urinary metabolite measurement · score 0.30
- viral load · score 0.26
- blood protein measurement · score 0.25
- Thyroid preparation use measurement · score 0.15
- hypothyroidism · score 0.11
- heel bone mineral density · score 0.08
- refractive error measurement · score 0.08
- appendicular lean mass · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43488-F1 | alphafold | PREDICTED | 93.06 | — |
Amino-acid sequence (359 residues)
MLSAASRVVS RAAVHCALRS PPPEARALAM SRPPPPRVAS VLGTMEMGRR MDAPASAAAV RAFLERGHTE LDTAFMYSDG QSETILGGLG LGLGGGDCRV KIATKANPWD GKSLKPDSVR SQLETSLKRL QCPQVDLFYL HAPDHGTPVE ETLHACQRLH QEGKFVELGL SNYASWEVAE ICTLCKSNGW ILPTVYQGMY NATTRQVETE LFPCLRHFGL RFYAYNPLAG GLLTGKYKYE DKDGKQPVGR FFGNSWAETY RNRFWKEHHF EAIALVEKAL QAAYGASAPS VTSAALRWMY HHSQLQGAHG DAVILGMSSL EQLEQNLAAT EEGPLEPAVV DAFNQAWHLV AHECPNYFR
Explore Aflatoxin B1 aldehyde reductase member 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets